Beijing, China

Xiaowen Yu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaowen Yu: Innovator in Molecular Biology

Introduction

Xiaowen Yu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of molecular biology, particularly in the development of lipid compositions that target antigen-presenting cells. His innovative work has implications for immunotherapy and disease treatment.

Latest Patents

Xiaowen Yu holds a patent for a lipid composition targeting antigen-presenting cells and its use. This patent, which is a testament to his expertise, focuses on enhancing the protein expression level of antigens in the spleen. The composition demonstrates good organ and cell targeting specificity, significantly increasing the percentage of cells that express the antigen among various antigen-presenting cells, such as B cells, pDC cells, cDC cells, and macrophages. This advancement indicates potential applications in immunotherapy for various diseases.

Career Highlights

Xiaowen Yu is associated with Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., where he continues to push the boundaries of research in molecular biology. His work is characterized by a commitment to innovation and the application of scientific principles to real-world health challenges.

Collaborations

Xiaowen has collaborated with notable colleagues, including Gengshen Song and Honglei Zhang. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Xiaowen Yu's contributions to molecular biology and his innovative patent highlight his role as a key figure in advancing immunotherapy. His work not only showcases his expertise but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…